Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 4, 2007

View Archived Issues

Marshall Edwards recruiting patients in phase III trial of phenoxodiol

NeuralSTEM and University of Michigan to collaborate on stem cell R&D

GlaxoSmithKline receives European authorization for Arixtra in the treatment of ACS

Positive results for Accera's phase II study of Ketasyn for memory in older adults

New analgesic agents described in recent patent literature

Novel agents for neurological disorders reported in recent Proximagen and Janssen patents

Recent Merck & Co. patent imparts new treatment option for atherosclerosis

Modulation of mGlu5 receptor activity may provide benefit in incontinence and overactive bladder

Merck Serono applies to EMEA for extension of Erbitux indication in mCRC

Amgen describes new 11beta-HSD1 inhibitors with potential use in treating type 2 diabetes

Abbott and AstraZeneca to advance ABT-335 and Crestor combination

FDA extends Astellas Pharma US's Mycamine for injection sNDA three months

Wistar Institute's novel HIV vaccine receives funding for clinical trials

Improved antitumor activity and safety profile of nitric oxide derivative of pegylated epirubicin

Neuroprotective effects of coumaric acid derivative identified

Smallpox vaccine ACAM-2000 approved by FDA

Mylan begins offers for senior notes towards acquisition of Merck's generic pharmaceutical business

Meridian Bioscience begins parvovirus B19 vaccine phase I/II trials

ThromboGenics completes technology transfer to Bharat Biotech for THR-100

Positive interim results from Avexa's phase IIb trial of apricitabine for HIV

E-5555 inhibits thrombin-induced platelet aggregation in healthy volunteers

Extended release niacin/laropiprant demonstrates efficacy in dyslipidemia

Studies show improved lipids, no blood pressure increase with MK-0859

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...